Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
BMC Cancer ; 24(1): 184, 2024 Feb 07.
Article in English | MEDLINE | ID: mdl-38326751

ABSTRACT

BACKGROUND: Sinonasal mucosal melanoma (SNMM) is a relatively rare malignant tumour with a poor prognosis. This study was designed to identify prognostic factors and establish a nomogram model to predict the overall survival (OS) of patients with SNMM. METHODS: A total of 459 patients with SNMM were selected from the Surveillance, Epidemiology, and End Results (SEER) database as the training cohort. Univariate and multivariate Cox regression analyses were used to screen for independent factors associated with patient prognosis and develop the nomogram model. In addition, external validation was performed to evaluate the effectiveness of the nomogram with a cohort of 34 patients with SNMM from Peking Union Medical College Hospital. RESULTS: The median OS in the cohort from the SEER database was 28 months. The 1-year, 3-year and 5-year OS rates were 69.8%, 40.4%, and 30.0%, respectively. Multivariate Cox regression analysis indicated that age, T stage, N stage, surgery and radiotherapy were independent variables associated with OS. The areas under the receiver operating characteristic curves (AUCs) of the nomograms for predicting 1-, 3- and 5-year OS were 0.78, 0.71 and 0.71, respectively, in the training cohort. In the validation cohort, the area under the curve (AUC) of the nomogram for predicting 1-, 3- and 5-year OS were 0.90, 0.75 and 0.78, respectively. Patients were classified into low- and high-risk groups based on the total score of the nomogram. Patients in the low-risk group had a significantly better survival prognosis than patients in the high-risk group in both the training cohort (P < 0.0001) and the validation cohort (P = 0.0016). CONCLUSION: We established and validated a novel nomogram model to predict the OS of SNMM patients stratified by age, T stage, N stage, surgery and radiotherapy. This predictive tool is of potential importance in the realms of patient counselling and clinical decision-making.


Subject(s)
Melanoma , Paranasal Sinus Neoplasms , Humans , Nomograms , Melanoma/therapy , Paranasal Sinus Neoplasms/therapy , Area Under Curve , Clinical Decision-Making , Prognosis , SEER Program
2.
J Clin Med ; 12(8)2023 Apr 13.
Article in English | MEDLINE | ID: mdl-37109185

ABSTRACT

(1) Background: Allergic rhinitis (AR) is a common disease in otolaryngology and novel biological therapies are required for clinical needs. To assess the tolerability of monoclonal antibodies, justifying their clinical applications, we presented a comprehensive safety profile of biologics in AR; (2) Methods: A systematic literature search was conducted following PRISMA guidelines for randomized clinical trials comparing monoclonal antibodies and placebo in AR. PubMed, Web of Science, Medline, and Cochrane were searched up until 9 January 2023. Among 3590 records in total, 12 studies with more than 2600 patients were included. Quality was assessed for all studies using Cochrane risk-of-bias tool for randomized trials, and subgrouped meta-analysis was performed; (3) Results: We accomplished an up-to-date literature overview and analysis on adverse events of monoclonal antibodies in AR. Total, common, severe, discontinuation-causing, and serious adverse events failed to reach statistical significance. Country was an essential factor for heterogeneity, and urticaria was the adverse event at highest risk (RR 2.81, 95% CI 0.79-9.95); (4) Conclusions: Monoclonal antibodies are considered well tolerated and relatively safe in patients with AR. The regions of patients and hypersensitive adverse reactions such as urticaria require a special caution in biological treatments in AR.

4.
Nat Immunol ; 23(10): 1484-1494, 2022 10.
Article in English | MEDLINE | ID: mdl-36138182

ABSTRACT

The heterogeneous cellular microenvironment of human airway chronic inflammatory diseases, including chronic rhinosinusitis (CRS) and asthma, is still poorly understood. Here, we performed single-cell RNA sequencing (scRNA-seq) on the nasal mucosa of healthy individuals and patients with three subtypes of CRS and identified disease-specific cell subsets and molecules that specifically contribute to the pathogenesis of CRS subtypes. As such, ALOX15+ macrophages contributed to the type 2 immunity-driven pathogenesis of one subtype of CRS, eosinophilic CRS with nasal polyps (eCRSwNP), by secreting chemokines that recruited eosinophils, monocytes and T helper 2 (TH2) cells. An inhibitor of ALOX15 reduced the release of proinflammatory chemokines in human macrophages and inhibited the overactivation of type 2 immunity in a mouse model of eosinophilic rhinosinusitis. Our findings advance the understanding of the heterogeneous immune microenvironment and the pathogenesis of CRS subtypes and identify potential therapeutic approaches for the treatment of CRS and potentially other type 2 immunity-mediated diseases.


Subject(s)
Nasal Polyps , Rhinitis , Sinusitis , Animals , Chronic Disease , Eosinophils , Humans , Mice , Nasal Mucosa
5.
Mol Med ; 27(1): 151, 2021 12 03.
Article in English | MEDLINE | ID: mdl-34861818

ABSTRACT

BACKGROUND: We investigated the feasibility of two biomarkers of endothelial damage (Syndecan-1 and thrombomodulin) in coronavirus disease 2019 (COVID-19), and their association with inflammation, coagulopathy, and mortality. METHODS: The records of 49 COVID-19 patients who were admitted to an intensive care unit (ICU) in Wuhan, China between February and April 2020 were examined. Demographic, clinical, and laboratory data, and outcomes were compared between survivors and non-survivors COVID-19 patients, and between patients with high and low serum Syndecan-1 levels. The dynamics of serum Syndecan-1 levels were also analyzed. RESULTS: The levels of Syndecan-1 were significantly higher in non-survivor group compared with survivor group (median 1031.4 versus 504.0 ng/mL, P = 0.002), and the levels of thrombomodulin were not significantly different between these two groups (median 4534.0 versus 3780.0 ng/mL, P = 0.070). Kaplan-Meier survival analysis showed that the group with high Syndecan-1 levels had worse overall survival (log-rank test: P = 0.023). Patients with high Syndecan-1 levels also had significantly higher levels of thrombomodulin, interleukin-6, and tumor necrosis factor-α. Data on the dynamics of Syndecan-1 levels indicated much greater variations in non-survivors than survivors. CONCLUSIONS: COVID-19 patients with high levels of Syndecan-1 develop more serious endothelial damage and inflammatory reactions, and have increased mortality. Syndecan-1 has potential for use as a marker for progression or severity of COVID-19. Protecting the glycocalyx from destruction is a potential treatment for COVID-19.


Subject(s)
COVID-19/blood , COVID-19/therapy , Endothelium/metabolism , Glycocalyx/metabolism , Syndecan-1/blood , Aged , Biomarkers/blood , Blood Coagulation , COVID-19/mortality , China/epidemiology , Cytokines/metabolism , Endothelium, Vascular/pathology , Female , Humans , Inflammation , Intensive Care Units , Interleukin-6/blood , Kaplan-Meier Estimate , Male , Middle Aged , Oxygen , ROC Curve , SARS-CoV-2 , Thrombomodulin/blood , Treatment Outcome , Tumor Necrosis Factor-alpha/blood
6.
Eur J Cardiothorac Surg ; 58(4): 745-751, 2020 Oct 01.
Article in English | MEDLINE | ID: mdl-32951058

ABSTRACT

OBJECTIVES: Coronavirus disease 2019 (COVID-19) is a global pandemic. Critically ill patients often require prolonged intubation for mechanical ventilation to support breathing; thus, the artificial airway must be managed by tracheotomy. Therefore, studies exploring appropriate and safe methods for tracheotomy that minimize the risks of nosocomial transmission are important. METHODS: A retrospective analysis of the clinical characteristics of 14 critically ill patients with COVID-19, who underwent bedside tracheotomy from March to April 2020 was conducted to summarize the indications for tracheotomy and key points related to personal protective equipment and surgical procedures. RESULTS: All 14 patients were diagnosed with COVID-19 and were critically ill. All tracheotomies were performed in the late phase of the infection course. The interval between the infection and tracheotomy was 33 days, and the median interval between intubation and tracheotomy was 25.5 days. The reverse transcription-polymerase chain reaction results of secretions from the operative incision and inside the tracheotomy tube were negative. Twelve patients improved after tracheotomy, with SpO2 levels maintained above 96%. One patient died of progressive respiratory failure; another patient died of uncontrolled septic shock. No medical staff who participated in the tracheotomy was infected. CONCLUSIONS: Tracheotomy in critically ill patients with COVID-19 who meet the indications for tracheotomy potentially represents a safer approach to manage the airway and help improve the treatment outcomes. A tracheotomy performed in the late phase of the disease has a relatively low risk of infection. Adherence to key steps in the tracheotomy procedure and donning adequate personal protection will help medical staff avoid infection.


Subject(s)
Airway Management/methods , Betacoronavirus , Coronavirus Infections/surgery , Infection Control/methods , Pneumonia, Viral/surgery , Tracheotomy/methods , Aged , Aged, 80 and over , Betacoronavirus/isolation & purification , COVID-19 , COVID-19 Testing , China , Clinical Laboratory Techniques , Coronavirus Infections/diagnosis , Coronavirus Infections/therapy , Coronavirus Infections/transmission , Critical Illness , Cross Infection/prevention & control , Female , Humans , Infection Control/instrumentation , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Male , Middle Aged , Pandemics , Personal Protective Equipment , Pneumonia, Viral/diagnosis , Pneumonia, Viral/therapy , Pneumonia, Viral/transmission , Retrospective Studies , SARS-CoV-2 , Treatment Outcome
7.
Head Face Med ; 16(1): 15, 2020 Jul 18.
Article in English | MEDLINE | ID: mdl-32682430

ABSTRACT

BACKGROUND: To investigate the prognostic value of a three-dimensional dynamic quantitative analysis system to measure facial motion (3D ASFM) in acute facial palsy patients and compare it with subjective grading methods and electroneurography. METHODS: We continuously recruited 37 patients with acute (< 1 month) Bell's palsy. An integrated evaluation of facial palsy was performed for each patient. The integrated evaluation included the House-Brackmann grading system (H-BGS), Sunnybrook Facial Grading System (SFGS), electroneurography and three-dimensional objective measurements. Then, the entire set of evaluations were repeated for each patient 1 month later. The patients were followed up monthly until recovery or for up to more than 6 months. We adopted the SFGS and H-BGS as the representative subjective grading system and final criteria for recovery. Poor recovery was defined as an SFGS score less than 70 or H-BGS score higher than II. RESULTS: Multiple regression analysis was performed to find the best prognostic indicators. In less than 1 month from onset, ENoG had the highest prognostic value. However, in the second month from onset, the results of SFGS and 3D ASFM were identified as the best prognostic parameters, and a prediction formula with a determination coefficient of 0.673 was established. The receiver operating characteristic curves revealed that a gross score of the 3D ASFM less than 31 in the first evaluation and 49 in the second evaluation had higher sensitivity and specificity to predict poor recovery. CONCLUSIONS: In different phases of Bell's palsy, the best predictor of prognosis is different. ENOG is the most effective predictor of the prognosis in the first month after onset. In the second month after onset, the combination of SFGS and 3D ADSM is considered to be the best prognostic predictor.


Subject(s)
Bell Palsy , Facial Paralysis , Face , Facial Paralysis/diagnosis , Humans , Male , Motion , Prognosis , ROC Curve
8.
Head Neck ; 42(10): 2821-2829, 2020 10.
Article in English | MEDLINE | ID: mdl-32677270

ABSTRACT

BACKGROUND: During surgical treatment of lesions involving the skull base, conductive hearing is often sacrificed due to tympanum destruction. This study aimed to develop a method for tympanum reconstruction using a sternocleidomastoid (SCM) flap to preserve conductive hearing during lateral skull base surgery. METHODS: This study included five patients with lateral skull base lesions who underwent surgery including tympanum reconstruction with an SCM flap between July 2015 and November 2017. RESULTS: Three patients seen with facial nerve schwannoma, and two had paraganglioma of the head and neck. All patients' inferior and posterior tympanic walls were resected; the tympanum and ossicular chain were reconstructed with an SCM flap and prosthesis. The mean postoperative air-bone gap was 14 dB. No lesion recurrences were observed until the last follow-up. CONCLUSION: The SCM flap is effective in preserving conductive hearing through reconstruction of the inferior and posterior tympanic walls in lateral skull base surgery.


Subject(s)
Plastic Surgery Procedures , Ear, Middle , Humans , Neoplasm Recurrence, Local , Retrospective Studies , Skull Base/surgery
9.
Acta Otolaryngol ; 138(1): 90-94, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28938861

ABSTRACT

OBJECTIVE: Scientific publication is the reflection of the capability of not only an individual scholar, but also a group, even a country. Over the past few decades, Chinese researchers have made great progress in medical scientific field. However, the status about the quantity and quality of the publications in otorhinolaryngology have not been reported. The aim of this study was to compare the output by Chinese authors from three regions of China: Mainland China (MC), Taiwan (TW) and Hong Kong (HK). METHODS: Literature was retrieved from the 43 otorhinolaryngology journals based on the subject category 'otorhinolaryngology' of the Science Citation Index Expanded (2015) from Web of Science Core Collection. The first authors of these articles were limited in three regions of China: MC, TW and HK from 2006 to 2016 by using the data mining software Thomson Data Analyzer (TDA). Evaluation criteria are based on total number of articles, impact factors (IFs), citations, articles published in high-impact journals and funding support. RESULT: A total of 59,832 articles were published worldwide in 43 otorhinolaryngology related journals from 2006 to 2016. Publications from MC was rapidly increasing and the total number contributed the most articles of the China (1931/3362, 57.44%), followed by TW (1220/3362, 36.29%) and HK (211/3362, 6.28%). The quantity of annual publications from MC has exceeded that of TW since 2010. MC was in the first place for cumulative IFs, but the last place for average IF. For total and average citations, MC was in the same situation of IF. Acta Otolaryngol was the most popular journal to choose in MC, and for TW and HK was Head & Neck. CONCLUSIONS: The total number of otorhinolaryngology articles in China increased markedly from 2006 to 2016, especially for MC. Despite the rapid growth in the number of articles from MC, the quality was not that satisfactory.


Subject(s)
Bibliometrics , Otolaryngology/statistics & numerical data , Periodicals as Topic/statistics & numerical data , China , Hong Kong , Otolaryngology/trends , Taiwan
10.
Arch Gerontol Geriatr ; 60(2): 311-6, 2015.
Article in English | MEDLINE | ID: mdl-25547994

ABSTRACT

OBJECTIVE: China has the most elderly people. Maintaining and improving the QOL of the elderly has emerged as a particularly important issue. This population-based study aimed to examine the QOL of the urban elderly and to clarify the associated factors. METHODS: A cross-sectional study was performed in Liaoning Province. The elderly people without senile dementia composed our study population and were interviewed from March to November, 2012 with questionnaires pertaining to QOL (SF-36), cognitive ability, demographic characteristics, health status, behavioral factors, and social-psychological factors. 4067 effective responses were received (effective response rate: 86.0%). After further cognitive screening, 3714 participants were included as the subjects. RESULTS: The mean scores of physical component summary (PCS) and mental component summary (MCS) were 53.7±21.5 (mean±SD) and 58.9±18.9, respectively. With adjustment for age and sex, general linear model analysis showed that, in standardized estimate (ß) sequence, PCS was significantly associated with chronic disease, taking a walk, visual ability, sleeping quality, marital status, alcohol consumption, hearing ability, smoking, neighborhood relationships, filial piety, ethnicity, and regular diet, and MCS was associated with chronic disease, sleeping quality, taking a walk, visual ability, marital status, ethnicity, filial piety, regular diet, alcohol consumption, smoking, and hearing ability. CONCLUSIONS: The community-dwelling elderly in urban areas had a low level of QOL. To improve QOL, the maintenance of health conditions was crucial. Efforts to encourage the elderly to perform feasible exercise and develop good lifestyles should be focused on. Also, children's filial duty to their parents should be enhanced.


Subject(s)
Quality of Life , Urban Population , Aged , Aged, 80 and over , Alcohol Drinking , China/epidemiology , Chronic Disease/epidemiology , Cross-Sectional Studies , Diet , Exercise , Female , Health Status , Hearing , Humans , Life Style , Male , Marital Status , Smoking/epidemiology , Surveys and Questionnaires , Walking
SELECTION OF CITATIONS
SEARCH DETAIL
...